Late presentation of patients with end-stage renal disease for renal replacement therapy - Is it always avoidable?

Nephrology Dialysis Transplantation

Volumn 26, Issue 11, 2011, Pages 3646-3651

  Udayaraj, Udaya P ^a   Haynes, Richard ^b   Winearls, Christopher G ^b  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

chronic kidney disease; end stage renal disease; late presentation; late referral; mortality

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT;

ACUTE KIDNEY FAILURE; ADULT; AGED; AORTA OCCLUSION; ARTICLE; AWARENESS; CAUSE OF DEATH; CHRONIC GLOMERULONEPHRITIS; COMORBIDITY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DEHYDRATION; DIABETIC NEPHROPATHY; DISEASE COURSE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INCIDENCE; KIDNEY AMYLOIDOSIS; KIDNEY ARTERIOVENOUS FISTULA; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIPLE MYELOMA; NEPHRECTOMY; NEPHROTOXICITY; PATIENT REFERRAL; PERCUTANEOUS CORONARY INTERVENTION; PERITONEAL DIALYSIS; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RISK FACTOR; SEPSIS; URINARY TRACT DISEASE; VASCULAR ACCESS; VASCULITIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROGNOSIS; QUALITY OF HEALTH CARE; REFERRAL AND CONSULTATION; RENAL REPLACEMENT THERAPY; SURVIVAL RATE; TIME FACTORS; YOUNG ADULT;

EID: 80155210247     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr164     Document Type: Article

References (37)

1. Winkelmayer WC, Glynn RJ, Levin R et al. Late referral and modality choice in end-stage renal disease. Kidney Int 2001; 60: 1547-1554
2. Roderick P, Jones C, Tomson C et al. Late referral for dialysis: Improving the management of chronic renal disease. QJM 2002; 95: 363-370
3. Cass A, Cunningham J, Arnold PC et al. Delayed referral to a nephrologist: Outcomes among patients who survive at least one year on dialysis. Med J Aust 2002; 177: 135-138
4. Schwenger V, Morath C, Hofmann A et al. Late referral-a major cause of poor outcome in the very elderly dialysis patient. Nephrol Dial Transplant 2006; 21: 962-967
5. Baer G, Lameire N, Van Biesen W. Late referral of patients with end stage renal disease: An in depth review and suggestions for further actions. NDT Plus 2010; 3: 17-27
6. Roderick P, Jones C, Drey N et al. Late referral for end-stage renal disease: A region-wide survey in the south west of England. Nephrol Dial Transplant 2002; 17: 1252-1259
7. Van Biesen W, Vanholder R, Veys N et al. The importance of standardization of creatinine in the implementation of guidelines and recommendations for CKD: Implications for CKD management programmes. Nephrol Dial Transplant 2006; 21: 77-83
8. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-S266
9. Glassock RJ, Winearls C. The global burden of chronic kidney disease: How valid are the estimates? Nephron Clin Pract 2008; 110: C39-c46; discussion c7
10. Noble E, Johnson DW, Gray N et al. The impact of automated eGFR reporting and education on nephrology service referrals. Nephrol Dial Transplant 2008; 23: 3845-3850
11. Glassock RJ, Winearls C. CKD in the elderly. Am J Kidney Dis 2008; 52: 803; author reply-4
12. Connor A, O'Donoghue D. Alternative view of CKD and QOF. BMJ 2010; 341: C3580
13. Van Biesen W, De Vecchi A, Dombros N et al. The referral pattern of end-stage renal disease patients and the initiation of dialysis: A European perspective. Perit Dial Int 1999; 19 (Suppl 2): S273-S275
14. Levin A. Consequences of late referral on patient outcomes. Nephrol Dial Transplant 2000; 15 (Suppl 3): 8-13
15. Lin CL, Chuang FR, Wu CF et al. Early referral as an independent predictor of clinical outcome in end-stage renal disease on hemodialysis and continuous ambulatory peritoneal dialysis. Ren Fail 2004; 26: 531-537
16. Roubicek C, Brunet P, Huiart L et al. Timing of nephrology referral: Influence on mortality and morbidity. Am J Kidney Dis 2000; 36: 35-41
17. Sesso R, Belasco AG. Late diagnosis of chronic renal failure and mortality on maintenance dialysis. Nephrol Dial Transplant 1996; 11: 2417-2420
18. Kessler M, Frimat L, Panescu V et al. Impact of nephrology referral on early and midterm outcomes in ESRD: EPidemiologie de l'Insuffisance REnale chronique terminale en Lorraine (EPIREL): Results of a 2-year, prospective, community-based study. Am J Kidney Dis 2003; 42: 474-485
19. Cass A, Cunningham J, Snelling P et al. Late referral to a nephrologist reduces access to renal transplantation. Am J Kidney Dis 2003; 42: 1043-1049
20. Arnold WP. Improvement in hemodialysis vascular access outcomes in a dedicated access center. Semin Dial 2000; 13: 359-363
21. Mendelssohn DC, Barrett BJ, Brownscombe LM et al. Elevated levels of serum creatinine: Recommendations for management and referral. CMAJ 1999; 161: 413-417
22. The CARI guidelines. Caring for Australians with Renal Impairment. 2002. http://www.kidney.org.au/cari/guidelines.php (20 December 2010, date last accessed).
23. European Renal Association. European Best Practice Guidelines Expert Group on hemodialysis. Nephrol Dial Transplant 2002; 17 (Suppl 7): 1-111
24. Codreanu I, Perico N, Sharma SK et al. Prevention programmes of progressive renal disease in developing nations. Nephrology (Carlton) 2006; 11: 321-328
25. Levey AS, Atkins R, Coresh J et al. Chronic kidney disease as a global public health problem: Approaches and initiatives-a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 2007; 72: 247-259
26. Archibald G, Bartlett W, Brown A et al. UK Consensus Conference on Early Chronic Kidney Disease-6 and 7 February 2007. Nephrol Dial Transplant 2007; 22: 2455-2457
27. Vassalotti JA, Stevens LA, Levey AS. Testing for chronic kidney disease: A position statement from the National Kidney Foundation. Am J Kidney Dis 2007; 50: 169-180
28. Imai E, Yamagata K, Iseki K et al. Kidney disease screening program in Japan: History, outcome, and perspectives. Clin J Am Soc Nephrol 2007; 2: 1360-1366
29. Keith DS, Nichols GA, Gullion CM et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004; 164: 659-663
30. Stevens PE, O'Donoghue DJ, de Lusignan S. Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney Int 2007; 72: 92-99
31. Coresh J, Astor BC, Greene T et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41: 1-12
32. Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047
33. Powe NR, Boulware LE. Population-based screening for CKD. Am J Kidney Dis 2009; 53: S64-70
34. Di Angelantonio E, Chowdhury R, Sarwar N et al. Chronic kidney disease and risk ofmajor cardiovascular disease and non-vascularmortality: Prospective population based cohort study. BMJ 2010; 341: C4986
35. Glassock RJ, Winearls C. Screening for CKD with eGFR: Doubts and dangers. Clin J Am Soc Nephrol 2008; 3: 1563-1568
36. Shlipak MG, Stehman-Breen C, Fried LF et al. The presence of frailty in elderly persons with chronic renal insufficiency. Am J Kidney Dis 2004; 43: 861-867
37. Johansen KL, Chertow GM, Jin C et al. Significance of frailty among dialysis patients. J Am Soc Nephrol 2007; 18: 2960-2967